Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease
- PMID: 26083617
- PMCID: PMC4509842
- DOI: 10.1097/MIB.0000000000000454
Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease
Abstract
Background: Inflammatory bowel disease (IBD) involves dysregulation of mucosal immunity in response to environmental factors such as the gut microbiota. The bacterial microbiota is often altered in IBD, but the connection to disease is not fully clarified and gut fungi have recently been suggested to play a role as well. In this study, we compared microbes from all 3 domains of life-bacteria, archaea, and eukaryota-in pediatric patients with IBD and healthy controls.
Methods: A stool sample was collected from patients with IBD (n = 32) or healthy control subjects (n = 90), and bacterial, archaeal, and fungal communities were characterized by deep sequencing of rRNA gene segments specific to each domain.
Results: Patients with IBD (Crohn's disease or ulcerative colitis) had lower bacterial diversity and distinctive fungal communities. Two lineages annotating as Candida were significantly more abundant in patients with IBD (P = 0.0034 and P = 0.00038, respectively), whereas a lineage annotating as Cladosporium was more abundant in healthy subjects (P = 0.0025). There were no statistically significant differences in archaea, which were rare in pediatric samples compared with those from adults.
Conclusions: Pediatric IBD is associated with reduced diversity in both fungal and bacterial gut microbiota. Specific Candida taxa were found to be increased in abundance in the IBD samples. These data emphasize the potential importance of fungal microbiota signatures as biomarkers of pediatric IBD, supporting their possible role in disease pathogenesis.
Conflict of interest statement
Disclosures: None of the authors have disclosures related to this manuscript.
Figures
References
-
- Richard ML, Lamas B, Liguori G, et al. Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2014 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UH2 DK083981/DK/NIDDK NIH HHS/United States
- UH3 DK083981/DK/NIDDK NIH HHS/United States
- K24 DK078228/DK/NIDDK NIH HHS/United States
- UH2DK083981/DK/NIDDK NIH HHS/United States
- P30 DK050306/DK/NIDDK NIH HHS/United States
- S10 RR024525/RR/NCRR NIH HHS/United States
- P30 AI045008/AI/NIAID NIH HHS/United States
- UL1RR024134/RR/NCRR NIH HHS/United States
- R01 GM103591/GM/NIGMS NIH HHS/United States
- P30 AI 045008/AI/NIAID NIH HHS/United States
- K24-DK078228/DK/NIDDK NIH HHS/United States
- S10RR024525/RR/NCRR NIH HHS/United States
- UL1 RR024134/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
